GB2188637B - Vaccines against melanoma - Google Patents

Vaccines against melanoma

Info

Publication number
GB2188637B
GB2188637B GB8702691A GB8702691A GB2188637B GB 2188637 B GB2188637 B GB 2188637B GB 8702691 A GB8702691 A GB 8702691A GB 8702691 A GB8702691 A GB 8702691A GB 2188637 B GB2188637 B GB 2188637B
Authority
GB
United Kingdom
Prior art keywords
vaccines against
against melanoma
melanoma
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB8702691A
Other versions
GB8702691D0 (en
GB2188637A (en
Inventor
Joseph P Brown
Gregory D Plowman
Karl E Hellstrom
Anthony F Purchio
Sridhar Pennathur
Charles D Estin
Timothy M Rose
Ingegerd Hellstrom
Shiu-Lok Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of GB8702691D0 publication Critical patent/GB8702691D0/en
Publication of GB2188637A publication Critical patent/GB2188637A/en
Application granted granted Critical
Publication of GB2188637B publication Critical patent/GB2188637B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/876—Skin, melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GB8702691A 1986-02-07 1987-02-06 Vaccines against melanoma Expired - Fee Related GB2188637B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen
FR878701335A FR2601370B1 (en) 1986-02-07 1987-02-04 MELANOMA VACCINE.

Publications (3)

Publication Number Publication Date
GB8702691D0 GB8702691D0 (en) 1987-03-11
GB2188637A GB2188637A (en) 1987-10-07
GB2188637B true GB2188637B (en) 1990-11-14

Family

ID=27251429

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8702691A Expired - Fee Related GB2188637B (en) 1986-02-07 1987-02-06 Vaccines against melanoma

Country Status (1)

Country Link
GB (1) GB2188637B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001973A2 (en) * 1987-09-02 1989-03-09 Applied Biotechnology, Inc. Recombinant pox virus for immunization against tumor-associated antigens
US6699475B1 (en) 1987-09-02 2004-03-02 Therion Biologics Corporation Recombinant pox virus for immunization against tumor-associated antigens
DK0498851T3 (en) * 1989-11-03 1996-05-13 Donald L Morton Tumor-associated urinary antigen, use of antigenic subunits and methods of detection
US5882654A (en) * 1989-11-03 1999-03-16 Morton; Donald L. Polyvalent melanoma vaccine
US5840317A (en) * 1989-11-03 1998-11-24 Morton; Donald L. Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen
AU2170692A (en) * 1991-06-05 1993-01-08 Bristol-Myers Squibb Company Me20: monoclonal antibodies and antigen for human melanoma
US5981194A (en) * 1992-07-10 1999-11-09 University Of British Columbia Use of p97 and iron binding proteins as diagnostic and therapeutic agents
AU4553793A (en) * 1992-07-10 1994-01-31 University Of British Columbia, The Use of p97 and iron binding proteins as diagnostic and therapeutic agents
EP2399586A1 (en) 2002-01-11 2011-12-28 Jefferies, Dr., Wilfred Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
CN103747807B (en) 2011-07-05 2016-12-07 比奥阿赛斯技术有限公司 P97 antibody conjugates and using method
WO2013022738A1 (en) 2011-08-05 2013-02-14 Bioasis Technologies, Inc. P97 fragments with transfer activity
EP2880156B1 (en) 2012-07-31 2017-08-23 biOasis Technologies Inc Dephosphorylated lysosomal storage disease proteins and methods of use thereof
AU2014243816B2 (en) 2013-03-13 2019-01-31 Bioasis Technologies Inc. Fragments of p97 and uses thereof
WO2015117121A1 (en) 2014-02-03 2015-08-06 Bioasis Technologies, Inc. P97 fusion proteins
DK3107562T3 (en) 2014-02-19 2019-12-16 Bioasis Technologies Inc P97-IDS FUSION PROTEIN

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DNA Cloning: *
Nature 1982 *
Pro Nat Acad *

Also Published As

Publication number Publication date
GB8702691D0 (en) 1987-03-11
GB2188637A (en) 1987-10-07

Similar Documents

Publication Publication Date Title
IL81481A0 (en) Vaccines against melanoma
EP0256878A3 (en) Vaccines
AR243868A1 (en) 3-aryloxy-3-substituted propanamines
GB2188637B (en) Vaccines against melanoma
GB8606707D0 (en) Combination feedboat
ZA872532B (en) Combined vaccine
GB8721453D0 (en) Ice-combative measures
ZW22487A1 (en) Vaccine
GB8619098D0 (en) Combination
ZA874847B (en) Oncornavirus vaccines
GR870195B (en) Vaccines against melanoma
GB8607072D0 (en) Retaining means
GB8615068D0 (en) Vaccines
GB8715304D0 (en) Retaining member
GB2194684B (en) Securing objects
PL264544A1 (en) Expresso
GB8621081D0 (en) Vaccines
GB2184937B (en) Coffee-maker
GB8620059D0 (en) Vaccines
GB8629988D0 (en) Vaccines
GB8604743D0 (en) Vaccines
GB8606559D0 (en) Vaccines
GB8606560D0 (en) Vaccines
GB8629475D0 (en) Vaccines
GB8708872D0 (en) Retaining means

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19990206